Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2025-12-26 @ 2:56 AM
Study NCT ID:
NCT04908202
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-24
First Post:
2021-05-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-13
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-06-10
Completion Date Type:
ESTIMATED
First Submit Date:
2021-05-28
First Submit QC Date:
None
Study First Post Date:
2021-06-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-09-02
Results First Submit QC Date:
None
Results First Post Date:
2025-10-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-08
Last Update Post Date:
2025-10-24
Last Update Post Date Type:
ESTIMATED